Angelos Papadopoulos
Angelos Papadopoulos has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Alex Kalinka
Joint AstraZeneca-Cancer Research Horizons Functional Genomics Centre
1 shared publication- Athena Kyrkou
Foundation for Research & Technology-Hellas (FORTH), Institute of Molecular Biology and Biotechnology (IMBB) 1 , Department of Biomedical Research, Ioannina, 45110 , Greece
1 shared publication - Carol Murphy
European Molecular Biology Laboratory, Heidelberg, Germany
1 shared publication - David Walter
Cancer Research Horizons, Cambridge, United Kingdom
1 shared publication - Douglas Ross-Thriepland
Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom
1 shared publication Ekaterini Panopoulou
University of Ioannina Medical School 3 Laboratory of Biological Chemistry Ioannina, 45110 , Greece
1 shared publication
Latest Publications
- Open Access
A benchmark comparison of CRISPRn guide-RNA design algorithms and generation of small single and dual-targeting libraries to boost screening efficiency
Genome-wide CRISPR sgRNA libraries have emerged as transformative tools to systematically probe gene function. While these libraries have been iterated over time to be more efficient, their large size limits their use in some applications. Here, we benchmarked publicly available genome-wide single-targeting sgRNA libraries and evaluated dual targeting as a strategy for pooled CRISPR loss-of-function screens. We leveraged this data to design two minimal genome-wide human CRISPR-Cas9 libraries that are 50% smaller than other libraries and that preserve specificity and sensitivity, thus enabling broader deployment at scale.
Open AccessA benchmark comparison of CRISPRn guide-RNA design algorithms and generation of small single and dual-targeting libraries to boost screening efficiency
Genome-wide CRISPR sgRNA libraries have emerged as transformative tools to systematically probe gene function. While these libraries have been iterated over time to be more efficient, their large size limits their use in some applications. Here, we benchmarked publicly available genome-wide single-targeting sgRNA libraries and evaluated dual targeting as a strategy for pooled CRISPR loss-of-function screens. We leveraged this data to design two minimal genome-wide human CRISPR-Cas9 libraries that are 50% smaller than other libraries and that preserve specificity and sensitivity, thus enabling broader deployment at scale.
- Open Access
- 1 July 2021
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 134 (13)
Embryonic stem cells are devoid of macropinocytosis, a trafficking pathway for activin A in differentiated cells
Ligand–receptor complexes formed at the plasma membrane are internalised via various endocytic pathways that influence the ultimate signalling output by regulating the selection of interaction partners by the complex along the trafficking route. We report that, in differentiated cells, activin A–receptor complexes are internalised via clathrin-mediated endocytosis (CME) and macropinocytosis (MP), whereas in human embryonic stem cells (hESCs) internalisation occurs via CME. We further show that hESCs are devoid of MP, which becomes functional upon differentiation towards endothelial cells through mesoderm mediators. Our results reveal, for the first time, that MP is an internalisation route for activin A in differentiated cells, and that MP is not active in hESCs and is induced as cells differentiate.
- 1 July 2021
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 134 (13)
Open AccessEmbryonic stem cells are devoid of macropinocytosis, a trafficking pathway for activin A in differentiated cells
Ligand–receptor complexes formed at the plasma membrane are internalised via various endocytic pathways that influence the ultimate signalling output by regulating the selection of interaction partners by the complex along the trafficking route. We report that, in differentiated cells, activin A–receptor complexes are internalised via clathrin-mediated endocytosis (CME) and macropinocytosis (MP), whereas in human embryonic stem cells (hESCs) internalisation occurs via CME. We further show that hESCs are devoid of MP, which becomes functional upon differentiation towards endothelial cells through mesoderm mediators. Our results reveal, for the first time, that MP is an internalisation route for activin A in differentiated cells, and that MP is not active in hESCs and is induced as cells differentiate.